Pain Management
Chronic pain, interventional pain medicine and opioid alternatives.
Pain medicine is being transformed by selective Nav1.8 sodium channel inhibition (suzetrigine/Journavx) for acute pain, expanded neuromodulation indications, and refined interventional techniques. The track will examine suzetrigine post-operative outcomes, low-dose ketamine infusions for refractory chronic pain and CRPS, and the maturation of dorsal root ganglion stimulation, closed-loop and high-frequency spinal cord stimulation, and peripheral nerve stimulation (Nalu, SPRINT). Interventional spine content covers cooled and conventional radiofrequency ablation for facet and SI joint pain, kyphoplasty, and minimally invasive SI joint fusion (iFuse, SI-Bone). Opioid stewardship, buprenorphine micro-induction, and cannabinoid evidence will be reviewed.
- Suzetrigine (Nav1.8 inhibition) for acute and post-operative pain
- Closed-loop and high-frequency spinal cord stimulation
- Dorsal root ganglion and peripheral nerve stimulation (Nalu, SPRINT)
- Cooled RFA for facet and SI joint pain; genicular RFA for knee OA
- Minimally invasive SI joint fusion (iFuse, SI-Bone) outcomes
- Ketamine infusions in chronic pain, CRPS, and depression overlap
- Buprenorphine micro-induction and opioid stewardship